These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11135350)

  • 1. Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues.
    Wu MC; Albert PS; Wu BU
    Stat Med; 2001 Jan; 20(1):93-108. PubMed ID: 11135350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs.
    Fitzmaurice GM; Laird NM; Shneyer L
    Stat Med; 2001 Apr; 20(7):1009-21. PubMed ID: 11276032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ignorability and bias in clinical trials.
    Heitjan DF
    Stat Med; 1999 Sep 15-30; 18(17-18):2421-34. PubMed ID: 10474150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
    Ali MW; Siddiqui O
    J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substitution therapy in alpha 1-antitrypsin deficiency].
    Konietzko N
    Pneumologie; 2001 Jan; 55(1):1-3. PubMed ID: 11236351
    [No Abstract]   [Full Text] [Related]  

  • 10. Examining the influence of drop-outs in a follow-up of maintained opiate users.
    Encrenaz G; Rondeau V; Messiah A; Auriacombe M
    Drug Alcohol Depend; 2005 Sep; 79(3):303-10. PubMed ID: 16102374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RAPID study: the first time the value of substitution therapy is verified].
    MMW Fortschr Med; 2016 Jun; 158(12):68-9. PubMed ID: 27462663
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation and comparison of rates of change in longitudinal studies with informative drop-outs.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Stat Med; 1999 May; 18(10):1215-33. PubMed ID: 10363341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1-antitrypsin augmentation therapy.
    Pierce JA
    Chest; 1997 Oct; 112(4):872-4. PubMed ID: 9377947
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed effects logistic regression models for longitudinal binary response data with informative drop-out.
    Ten Have TR; Kunselman AR; Pulkstenis EP; Landis JR
    Biometrics; 1998 Mar; 54(1):367-83. PubMed ID: 9544529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for treatment differences with dropouts present in clinical trials--a composite approach.
    Shih WJ; Quan H
    Stat Med; 1997 Jun; 16(11):1225-39. PubMed ID: 9194269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical handling of drop-outs in longitudinal clinical trials.
    Harris RI
    Stat Med; 1993 Dec; 12(23):2248-50. PubMed ID: 8310194
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
    Lane P
    Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-antitrypsin deficiency.
    Gøtzsche PC; Johansen HK
    N Engl J Med; 2009 Nov; 361(21):2101-2; author reply 2102. PubMed ID: 19923584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.